VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 8662 · 116th Congress

Accelerating Access to Critical Therapies for ALS Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

JFR FortenberrySponsor
278 cosponsors · 162 D, 116 R
MAR Amodei JBD Beatty DBR Bacon NBD Barragán ABR Biggs KCR Calvert JCD Costa GCD Cisneros MDR Diaz-Balart VDD Demings CFR Fleischmann GGR Gianforte KHR Hern JHR Hagedorn PKR King SKR King JKR Katko ALD Lowenthal CMR McMorris Rodgers DMR McKinley MMR Mullin RMR Marshall END Norton TOD O’Halleran CPD Peterson MQD Quigley BRD Rush JRR Rutherford HRD Rouda JSD Schakowsky ASD Schiff DSD Scott ASR Smith DSR Schweikert TSD Sewell SSR Stivers WTR Timmons FUR Upton NVD Velázquez PWD Welch BWR Westerman LBD Blunt Rochester JGD Golden DJR Joyce MLD Levin APD Pressley KPD Porter LTD Trahan BWR Wenstrup CAD Axne BFR Fitzpatrick RGD Grijalva AGR Gonzalez BMR Mast CPD Pingree GRR Reschenthaler ASD Spanberger GBR Bilirakis MCD Cartwright AKD Kirkpatrick BGR Guthrie RKD Khanna CMD Maloney TMD Malinowski RBR Bishop GCD Connolly SDD DelBene DED Evans SJD Jackson Lee RKD Krishnamoorthi JMD McNerney GMD Meng PRR Roe DSD Soto MSD Scanlon JBR Baird HCD Cuellar RGD Gallego JHR Hill DKD Kildee JLD Langevin CMR Miller BPR Posey DPD Payne CRD Ruppersberger JRD Raskin LSD Sánchez MSD Sherrill HSD Stevens JVR Van Drew KBR Brady RCR Crawford JCD Crow DDD DeGette CHR Higgins SMD Murphy ASR Scott JSR Smith GSD Stanton GTR Thompson TBR Burchett JCD Correa BCR Cline SDR DesJarlais RDR Davis NDR Dunn MGR Gallagher AHR Harris GHR Holding JHD Harder DKD Kilmer JMD McGovern DND Norcross TRD Ryan ASD Sires TSD Suozzi TTR Tiffany PTD Tonko RWR Wittman SWR Womack SBR Brooks BBR Babin SCR Chabot DCD Cicilline LFD Frankel GGR Grothman MKR Kelly AKD Kim FLR Lucas ALD Lawson SMD Maloney SMD Moulton JSD Speier ESD Swalwell DWD Wasserman Schultz RWR Weber MWR Waltz MBR Brooks TDD Deutch VGD Gonzalez AHD Hastings HJD Johnson DLR LaMalfa SLD Lee GMD Meeks JMD Morelle GND Napolitano EPD Perlmutter KRD Rice BSD Schneider ESR Stefanik JYD Yarmuth RAR Abraham SBD Bishop BBD Boyle TCR Cole SCD Carbajal ACD Craig DDD Davis MDD Dean BFD Foster AFR Ferguson VHR Hartzler TKR Kelly ZLD Lofgren DLR LaHood CLD Lamb MMR McCaul GMD Moore JMR Moolenaar JND Neguse DPD Phillips MRD Rose WSR Steube BTD Thompson DTD Trone TYR Yoho LZR Zeldin ABR Barr ABD Bera KBR Buck JCD Cooper SCD Cohen ADD Delgado LFD Fletcher AGD Green JGD Garamendi BGR Gibbs WKD Keating SLD Lynch AMR Mooney SPD Peters LRD Roybal-Allard CAD Allred JBD Brownley ABD Brown WCD Clay YCD Clarke ACD Carson PCR Cook KCD Clark BCR Carter JCR Comer PDD DeFazio SDD Davis SDD Davids BFR Flores MGR Garcia JHD Huffman JHR Hice CHD Houlahan RKD Kelly BLR Loudermilk DLR Lesko BMD McCollum JPD Panetta DRR Riggleman CSR Stewart SWR Watkins JWD Wexton PAD Aguilar FKR Keller DMD Matsui DMR Meuser DLD Loebsack TMR McClintock JSD Sarbanes DYR Young RAR Aderholt JBR Bergman MDD DeSaulnier PGR Gosar JHD Hayes ELD Luria KMD Mfume LMD McBath SPR Palazzo CRD Richmond CSR Smith LSR Smucker AFD Finkenauer JHR Herrera Beutler DLR Lamborn BMD McAdams JSD Serrano MSR Simpson JWR Wilson TBR Balderson AED Espaillat HJD Jeffries MTD Thompson JCD Courtney JDR Duncan RER Estes SGR Graves BHR Huizenga DHD Haaland MKD Kaptur BLD Lee JLD Larson BLR Luetkemeyer TLD Lieu CPD Pappas ASD Smith SSR Scalise MTR Turner BWD Watson Coleman SWD Wild BHD Higgins BSD Sherman JCR Curtis VED Escobar MJR Johnson ESD Slotkin ABD Brindisi NTD Torres JGD Gottheimer AKD Kuster

41 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions.

What it does: CRS summary · Introduced in House · Oct 23, 2020

Accelerating Access to Critical Therapies for ALS Act

This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions.

The Department of Health and Human Services (HHS) shall award grants to eligible entities to support research on and facilitate access to investigational drugs that diagnose or treat ALS. The Food and Drug Administration shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other severely debilitating neurodegenerative diseases.

HHS shall also establish the Collaborative for Neurodegenerative Diseases, which shall support the development and regulatory approval of drugs that address ALS and other rare neurodegenerative diseases.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Accelerating Access to Critical Therapies for ALS Act

Latest action (Oct 23, 2020): Referred to the House Committee on Energy and Commerce.

Policy area: Health · Origin: House · Introduced: Oct 23, 2020

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.